NCT03942458View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

June 28, 2019

Study Completion Date

September 3, 2019

Conditions
Healthy SubjectsPK/PD
Interventions
DRUG

Vicagrel 6mg

Vicagrel 24mg loading followed by 6mg/day for 6 days

DRUG

Clopidogrel 75mg

Clopidogrel 300mg loading followed by 75mg/day for 6 days

Trial Locations (1)

130021

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY

NCT03942458 - Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19 | Biotech Hunter | Biotech Hunter